Curcumin inhibits hepatitis B virus via down-regulation of the metabolic coactivator PGC-1α

Endpoints of therapy in chronic hepatitis B

(2010) Jordan J. Feld et al.   HEPATOLOGY

The metabolic activator FOXO1 binds hepatitis B virus DNA and activates its transcription

(2009) Amir Shlomai et al.   BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS

Ubiquitin-independent p53 proteasomal degradation

(2009) P Tsvetkov et al.   CELL DEATH AND DIFFERENTIATION

Curcumin inhibits hepatitis C virus replication via suppressing the Akt-SREBP-1 pathway

(2009) KyeongJin Kim et al.   FEBS LETTERS

Antiviral effect of Curcuma longa Linn extract against hepatitis B virus replication

(2009) Hye Jin Kim et al.   JOURNAL OF ETHNOPHARMACOLOGY

The nanny model for IDPs

(2009) Peter Tsvetkov et al.   Nature Chemical Biology

The “metabolovirus” model of hepatitis B virus suggests nutritional therapy as an effective anti-viral weapon

(2008) Amir Shlomai et al.   MEDICAL HYPOTHESES

Pharmacological basis for the role of curcumin in chronic diseases: an age-old spice with modern targets

(2008) Bharat B. Aggarwal et al.   TRENDS IN PHARMACOLOGICAL SCIENCES